Rejuveron Life Sciences

company

About

Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies.

  • 1 - 10

Details

Last Funding Type
Series A
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
Incubator,PE,Venture Capital

Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy aging and prolong lifespan.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
Fr22.50M
Rejuveron Life Sciences has raised a total of Fr22.50M in funding over 2 rounds. Their latest funding was raised on Mar 17, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 17, 2022 Series B 1 Detail
Dec 9, 2020 Series A 1 Detail
Dec 1, 2020 Series A Fr22.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Rejuveron Life Sciences is funded by 2 investors. Gaingels and Korify Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Gaingels Series B
Korify Capital Series A